AstraZeneca Can't Prevent FDA Approval Of Generic Seroquel
A Washington federal judge on Friday tossed AstraZeneca PLC's suit seeking to delay the launch of generic versions of its blockbuster anti-psychotic drug Seroquel with labels that omit hyperglycemia warnings AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article